Advertisements



Akela Pharma plans IPO

Read full story for latest details......»»

Category: ipoSource: cnnApr 27th, 2018

Zosano Pharma confirms plans to proceed with PK study after FDA protocol review

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021

Why Mustang Bio, Phathom Pharma And More Are Moving Today

Mustang Bio (NASDAQ: MBIO) shares are trading higher after the company announced the FDA has lifted the clinical hold for its pivotal phase 2 MB-107 clinical trial. The company plans to enroll the first patient in the second quarter of 2021. read more.....»»

Category: blogSource: benzingaFeb 2nd, 2021

Albireo Pharma plans to initiate trial in biliary atresia in 1H20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 2nd, 2020

Dispensed: Big Pharma"s plans to compete with buzzy startups, Sanofi"s entrance to the coronavirus vaccine race, and a Medicare Advantage pitch deck

Courtesy Rx Clinic Pharmac.....»»

Category: topSource: businessinsiderFeb 21st, 2020

Pharma giant Eli Lilly and Company taps Durham for 450+ jobs

Eli Lilly and Company plans to bring more than 462 jobs to a new Durham County facility. The drug giant picked Durham County for a $474 million investment over competing sites in both Indiana and Pennsylvania. The announcement was made Tuesday. E.....»»

Category: topSource: bizjournalsJan 21st, 2020

Astellas bets $3 billion in gene therapy deal

Shares of Astellas Pharma Inc. rose about 1% in premarket trading after the Japanese drugmaker said Monday evening that it plans to acquire Audentes.....»»

Category: topSource: marketwatchDec 3rd, 2019

Triangle drugmaker plans merger with Israeli pharma

The merger of a Triangle public drugmaker and an Israeli outfit led by former-Salix executives could have huge potential for Raleigh and its gastrointestinal candidates......»»

Category: topSource: bizjournalsOct 8th, 2019

Oyster Point Pharma looks to raise up to $85 million in IPO

Oyster Point Pharma Inc. said late Friday it plans to launch an initial public offering, according to a filing w.....»»

Category: topSource: marketwatchOct 4th, 2019

Plans for a biotech, pharma hub stall in Elk Grove

Plans to open a new biotech and pharmaceutical hub in Elk Grove have interest. It's finding space that's the hard part......»»

Category: topSource: bizjournalsSep 10th, 2019

Regeneron plans $800M NY production push, workforce growth, Fierce Pharma says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 14th, 2019

Pharma-owned plasma center set for major expansion in metro Phoenix

Plans call for opening four centers this year that would employ 140 people in the region......»»

Category: topSource: bizjournalsJun 28th, 2019

Englewood pharma company announces public offering of stock

The company plans to offer up to $12 million of its stock......»»

Category: topSource: bizjournalsJun 17th, 2019

California"s Kite Pharma plans to hire hundreds at new Frederick facility

Los Angeles biopharmaceutical company Kite Pharma plans to open a new manufacturing facility in Frederick County that will produce cell therapies for people with cancer. The company, a subsidiary of Gilead Sciences (NASDAQ: GILD), will build its.....»»

Category: topSource: bizjournalsApr 24th, 2019

Pharma distributors jump after Amazon reportedly shelves drug selling plans

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President"s Healthcare Plans

Your Daily Pharma Scoop: Omeros Up On Update, Synergy Sales, President"s Healthcare Plans.....»»

Category: topSource: seekingalphaMay 14th, 2018

Breakingviews TV - Trump drug dump

The president has unveiled long-promised plans to bring down the price of prescription medication. Antony Currie and Robert Cyran explain how it’s far more of a sop to the pharma industry than a salve for overcharged consumers......»»

Category: videoSource: reutersMay 15th, 2018

Flex Pharma Down on Workforce Reduction, Ends Phase II Study

Flex Pharma (FLKS) announced that the company is ending the phase II studies for its pipeline candidate FLX-787 in two indications. The company also plans to lower its workforce by about 60%. F.....»»

Category: smallbizSource: nytJun 14th, 2018

Perrigo plans to separate prescription pharma business

Perrigo Co Plc said on Thursday it would separate its generics prescription business, which has been a drag on results, to focus on consumer healthcare following a strategic review, sending the drugmaker's shares down about 8 percent......»»

Category: topSource: reutersAug 9th, 2018

Medical-marijuana company GW Pharma to sell $300 million in stock offering

GW Pharmaceuticals PLC said late Monday that it plans to sell $300 million worth of American depositary shares. Shares in the company fell 1.6% after hours. GW is a U.K.-based pharmaceutical company that.....»»

Category: topSource: marketwatchOct 1st, 2018

Goldman Sachs Takes Action on Pharma Stocks

WellCare Health Plans and Regeneron Pharmaceuticals are on the conviction buy listRelated Stocks: WCG, CTMX, REGN, UHS, GS,.....»»

Category: blogSource: gurufocusDec 14th, 2018